Policy Maker Marburger: Genomics Is ‘Only the Beginning’ | GenomeWeb

John Marburger, a Democrat appointed last year as director of the Office of Science and Technology Policy for the White House, is in a key position to keep genomics on the radar of federal policy makers. Former head of DOE’s Brookhaven National Laboratory, he oversaw the lab’s role in the Human Genome Project as well as its proteomics program. Marburger took some time to answer GT’s questions about his post, the future of genomics, and federal funding.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

A Karmagenes researcher has lost his position after reportedly admitting to data fabrication, according to Retraction Watch.

Two neuroscientists write in Nature News that solving the "reproducibility crisis" in science may require changing the requirements for publication.

In Nature this week: genomic analysis of prehistoric New Mexicans, a nanopore method for mapping DNA methylation, and more.

A new study finds that adding missing good bacteria to the skin microbiome of atopic dermatitis patients decreases Staphylococcus aureus colonization.